The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis - Top-Institutions - MDSpire

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis

  • By

  • Manfred Hauben

  • Rave Harpaz

  • July 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women’s Hospital and Harvard Medical School
    Brigham and Women’s Hospital and Harvard Medical School

    Boston, Massachusetts

    Key Differentiators

    • Pharmacoepidemiology
    • Drug Safety

  • #2

    Columbia University Irving Medical Center
    Columbia University Irving Medical Center

    New York, New York

    Key Differentiators

    • Biomedical Informatics
    • Drug Safety

  • #3

    Society for Epidemiologic Research
    Society for Epidemiologic Research

    Not specified, Not specified

    Key Differentiators

    • Epidemiology

  • #4

    Innovative Medicines Initiative (IMI) PROTECT
    Innovative Medicines Initiative (IMI) PROTECT

    Not specified, Not specified

    Key Differentiators

    • Pharmacovigilance

  • #5

    European Medicines Agency (EMA)
    European Medicines Agency (EMA)

    Not specified, Not specified

    Key Differentiators

    • Regulatory Affairs

Original Source(s)

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis

  • by Manfred Hauben, Rave Harpaz

  • July 1, 2026

Related Content

Hypoxia-driven tumor immune escape: mechanisms and therapeutic opportunities

Real-world evidence on data quality in precision oncology platforms: insights from the Molecular Twin Research Umbrella protocol

Bladder metastasis from gastric cancer presenting as acute post-renal obstruction during immunotherapy: a case report